Skip to main content
Signal8

Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026

$KTTAPress releaseOct 28, 2026, 4:05 PM ET

Pasithea Therapeutics will host a virtual KOL event on NF1 treatment on Wednesday, November 4, 2026, at 11:00 a.m. ET, focused on cutaneous and plexiform neurofibromas. The panel features NF1 specialists Dr. Rebecca Brown (UAB) and Dr.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    KTTA: Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026 — AI Analysis | Signal8